Randomized phase III study comparing the first-line chemotherapy regimens in patients with driver mutation-negative advanced non-small cell lung cancer and poor performance status complicated with chronic obstructive pulmonary disease

Gao, GY; Zhou, CZ; Huang, YC; Hong, ZY; Yu, P; Chen, Y; Gao, JB; Zhang, KN; Xie, ZH; Zhang, JX; Li, SY; Masashi, N; Qin, YY

Qin, YY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,State Key Lab Resp Dis, Guangzhou, Peoples R China.; Qin, YY (corresponding author), Guangzhou Med Univ, Shunde Affiliated Hosp, Lecong Hosp Shunde Dist, Pulm & Crit Care Med, Foshan 528315, Peoples R China.

TRANSLATIONAL LUNG CANCER RESEARCH, 2021; 10 (6): 2573

Abstract

Background: Patients with non-small cell lung cancer (NSCLC) complicated with chronic obstructive pulmonary disease (COPD) with poor performance statu......

Full Text Link